Karaca Sibel, Kırlı Meltem
Erzurum Regional Training and Research Hospital, Erzurum, Turkey.
J Gastrointest Oncol. 2019 Jun;10(3):506-512. doi: 10.21037/jgo.2019.02.03.
Cervical esophageal cancer (CEC) patients may suffer from significant anatomical changes due to tumor shrinkage or weight loss during radiotherapy. The aim of the study is to evaluate the volumetric and dosimetric changes in the target and critical volumes of CEC patients by using adaptive radiotherapy (ART) technique.
Seven CEC patients treated in helical tomotherapy (HT) unit was analyzed. All patients had a replanning CT simulation at 3rd (CT2) and 5th (CT3) weeks in addition to the initial CT (CT1). Volumetric and dosimetric changes of target and organs at risk (OAR) were evaluated.
The average weight loss of the patients was 9.03%. The major changes of the planning target volume (PTV), PTV boost, right and left parotid volumes were 4.74%; 15.93%; 26.82% and 26.64%, respectively. Using ART software was evaluated with first planning values (CT1) and pre-CT2-CT3 verification values. The correlation was decrease of the D95 and increase of the Dmax was statistically significant. When evaluated the varying values of the new CTs, there was no significant change between the initial PTV and adapted PTV's. But a significant decrease was observed at the summation plan for left and right parotids (P<0.05). The mean dose reductions of left and right parotid were 2.48 and 2.49 Gy, respectively.
Our results showed that using ART technique was beneficial to ensure adequate doses to the target volumes and safe doses to the OARs for the patients who need replanning during RT in uncommon CEC patients.
由于放疗期间肿瘤缩小或体重减轻,颈段食管癌(CEC)患者可能会出现显著的解剖结构变化。本研究旨在通过使用自适应放疗(ART)技术评估CEC患者靶区和危及器官体积及剂量的变化。
分析了7例在螺旋断层放疗(HT)设备上接受治疗的CEC患者。除初始CT(CT1)外,所有患者在第3周(CT2)和第5周(CT3)均进行了重新计划CT模拟。评估了靶区和危及器官(OAR)的体积和剂量变化。
患者的平均体重减轻了9.03%。计划靶区(PTV)、PTV加量区、左右腮腺体积的主要变化分别为4.74%、15.93%、26.82%和26.64%。使用ART软件根据首次计划值(CT1)和CT2 - CT3前验证值进行评估。D95降低和Dmax升高的相关性具有统计学意义。当评估新CT的变化值时,初始PTV与自适应PTV之间无显著变化。但左右腮腺的总和计划中观察到显著降低(P<0.05)。左右腮腺的平均剂量分别降低了2.48 Gy和2.49 Gy。
我们的结果表明,对于罕见的CEC患者放疗期间需要重新计划的患者,使用ART技术有利于确保靶区获得足够剂量,同时确保危及器官接受安全剂量。